Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Kaipu Biochemical is a specialized manufacturer of biochemicals, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs) based in China. The company focuses primarily on nucleoside and nucleotide chemistry, producing a broad range of derivatives used in the synthesis of antiviral and antineoplastic medications. Their product catalog includes various protected nucleosides and derivatives of adenosine, cytidine, guanosine, and uridine. As a key supplier to the global life sciences industry, the company provides high-quality chemical building blocks for drug discovery and large-scale pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Kaipu Biochemical.